Name: UMIN ID:
Unique ID issued by UMIN | UMIN000029636 |
---|---|
Receipt number | R000033843 |
Scientific Title | A phase 2 trial of Nivolumab in recurrent or metastatic platinum-refractory non-squamous cell carcinoma of the head and neck |
Date of disclosure of the study information | 2017/10/20 |
Last modified on | 2023/11/02 17:39:54 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/10/20 10:08:58 | ||
2 | Update | 2017/10/20 11:05:26 | Email1 |
|
3 | Update | 2018/03/29 20:00:11 | Recruitment status Date of protocol fixation |
|
4 | Update | 2018/03/29 20:02:17 | Institutions |
|
5 | Update | 2018/04/13 13:47:05 | Institutions |
|
6 | Update | 2018/10/22 15:26:58 | Anticipated trial start date |
|
7 | Update | 2019/04/22 17:31:14 | Interventions/Control_1 Interventions/Control_1 |
|
8 | Update | 2019/10/21 19:28:33 | Date of IRB Last follow-up date |
|
9 | Update | 2022/10/24 18:16:17 | Recruitment status |
|
10 | Update | 2023/11/02 17:39:54 | Recruitment status |